SCHEMBL269648

SCHEMBL269648

CCC[C](C)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL271353 0.77
SCHEMBL6085491 0.74
SCHEMBL20377393 0.72 GPR84 (0.57)
SCHEMBL5360973 0.72 GPR84 (0.57)
SCHEMBL20377385 0.72 GPR84 (0.57)
SCHEMBL6751385 0.72
SCHEMBL20377396 0.72 GPR84 (0.57)
SCHEMBL9506597 0.72 GPR84 (0.57)
SCHEMBL20377398 0.72 GPR84 (0.57)
SCHEMBL20377386 0.72 GPR84 (0.57)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 633 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240238774-A1 TWO COMPONENT ION EXCHANGE RESINS ION EXCHANGE (INDIA) LIMITED (IN) 2024-07-18 US claimed
EP-4373599-A1 TWO COMPONENT ION EXCHANGE RESINS Ion Exchange (India) Limited (IN) 2024-05-29 EP claimed
US-20230404924-A1 MODIFIED RELEASE FORMULATIONS AND USES THEREOF SUNOVION PHARMACEUTICALS INC. 2023-12-21 US claimed
US-11654113-B2 Modified release formulations and uses thereof SUNOVION PHARMACEUTICALS INC. (US) 2023-05-23 US claimed
WO-2023002498-A1 TWO COMPONENT ION EXCHANGE RESINS ION EXCHANGE (INDIA) LIMITED (IN) 2023-01-26 WO claimed
US-20220117899-A1 MODIFIED RELEASE FORMULATIONS AND USES THEREOF SUMITOMO DAINIPPON PHARMA COMPANY, LIMITED (JP) 2022-04-21 US claimed
US-11192343-B2 Self-destructive irreversible security packaging film ARROW GREENTECH LIMITED (IN) 2021-12-07 US claimed
US-11160758-B2 Modified release formulations and uses thereof SUNOVION PHARMACEUTICALS INC. (US) 2021-11-02 US claimed
US-11039637-B2 Composition and method for improving stability and extending shelf life of probiotic bacteria and food products thereof DEGAMA BERRIER LTD. (KY) 2021-06-22 US claimed
EP-3626236-A1 SUSTAINED RELEASE FORMULATION OF NALTREXONE Nalpropion Pharmaceuticals, Inc. (US) 2020-03-25 EP claimed
WO-2000061375-A1 PHOTOGRAPHIC QUALITY INKJET PRINTABLE COATINGS ALLIEDSIGNAL INC. (US) 2000-10-19 WO claimed
EP-1035840-A1 SUSTAINED RELEASE FORMULATION CONTAINING THREE DIFFERENT TYPES OF POLYMERS AND TABLET FORMED THEREFROM Duramed Pharmaceuticals Inc. (US) 2000-09-20 EP claimed
US-6083532-A TABLETS FOR SUSTAINED RELEASE OF DRUGS AND GELLING POLYMER DURAMED PHARMACEUTICALS, INC. (US) 2000-07-04 US claimed
EP-0892744-B1 WATER SOLUBLE BAG PACKAGING SYSTEM AND METHOD FOR PACKAGING NOVARTIS AG (CH) 2000-06-07 EP claimed
WO-1999029305-A1 SUSTAINED RELEASE FORMULATION CONTAINING THREE DIFFERENT TYPES OF POLYMERS AND TABLET FORMED THEREFROM DURAMED PHARMACEUTICALS, INC. (US) 1999-06-17 WO claimed
EP-0892744-A1 WATER SOLUBLE BAG PACKAGING SYSTEM AND METHOD FOR PACKAGING Novartis AG (CH) 1999-01-27 EP claimed
WO-1998045185-A1 WATER SOLUBLE PACKAGING SYSTEM, FILM AND METHOD NOVARTIS AG (CH) 1998-10-15 WO claimed
WO-1997037903-A1 WATER SOLUBLE BAG PACKAGING SYSTEM AND METHOD FOR PACKAGING NOVARTIS AG (CH) 1997-10-16 WO claimed
US-5089277-A Shapable body containing blend of water soluble cellulose ether, polyoxyalkylene glycol, water; controlled dispersion BERKLEY, INC. (US) 1992-02-18 US claimed
US-4853437-A Water- and caustic-insoluble, inswellable, fibrous, particulate crosslinked polymer HERCULES INCORPORATED (US) 1989-08-01 US claimed